AHCO AdaptHealth Corp
- Stocks
- Healthcare
- NASDAQ: AHCO
Price (delayed)
$9.74
Market cap
$1.32B
P/E Ratio
17.39
Dividend/share
N/A
EPS
$0.56
Enterprise value
$3.14B
Relative Growth:
Rel. Growth:
67
Relative Strength:
Rel. Strength:
59
Relative Valuation:
Rel. Valuation:
95
Relative Profitability:
Rel. Profitability:
59
AdaptHealth is a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States. AdaptHealth provides a full suite of medical products and
Highlights
The net income has soared by 138% YoY and by 2% from the previous quarter
The EPS has surged by 134% year-on-year
AHCO's quick ratio is down by 24% year-on-year and by 7% since the previous quarter
The price to earnings (P/E) is 10% higher than the last 4 quarters average of 16.8
Key stats
What are the main financial stats of AHCO
Market
Valuations
Earnings
Shares outstanding
135.42M
Market cap
$1.32B
Enterprise value
$3.14B
Price to earnings (P/E)
17.39
Price to book (P/B)
0.82
Price to sales (P/S)
0.4
PEG
0.13
EV/EBIT
12.09
EV/EBITDA
4.62
EV/Sales
0.97
Revenue
$3.26B
Gross profit
$750.33M
Operating income
$261.82M
Net income
$82.24M
EBIT
$259.93M
EBITDA
$679.89M
Free cash flow
$213.17M
Per share
Balance sheet
Liquidity
EPS
$0.56
EPS diluted
$0.55
Free cash flow per share
$1.58
Book value per share
$11.95
Revenue per share
$24.05
TBVPS
$12.12
Total assets
$4.38B
Total liabilities
$2.76B
Debt
$1.9B
Equity
$1.62B
Working capital
$54.13M
Debt to equity
1.18
Current ratio
1.08
Quick ratio
0.69
Net debt/EBITDA
2.68
Margins
Efficiency
Dividend
EBITDA margin
20.9%
Gross margin
23.1%
Net margin
2.5%
Operating margin
8%
Return on assets
1.9%
Return on equity
5.2%
Return on invested capital
8.7%
Return on capital employed
7%
Return on sales
8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AHCO stock price
How has the AdaptHealth stock price performed over time
Intraday
-5.8%
1 week
8.83%
1 month
8.71%
1 year
-4.32%
YTD
2.31%
QTD
8.83%
Financial performance
How have AdaptHealth's revenue and profit performed over time
Revenue
$3.26B
Gross profit
$750.33M
Operating income
$261.82M
Net income
$82.24M
Gross margin
23.1%
Net margin
2.5%
The net income has soared by 138% YoY and by 2% from the previous quarter
The net margin has soared by 138% year-on-year
The gross profit has declined by 5% year-on-year
AHCO's gross margin is down by 4.9% year-on-year
Price vs fundamentals
How does AHCO's price correlate with its fundamentals
Growth
What is AdaptHealth's growth rate over time
Valuation
What is AdaptHealth stock price valuation
P/E
17.39
P/B
0.82
P/S
0.4
EV/EBIT
12.09
EV/EBITDA
4.62
EV/Sales
0.97
The EPS has surged by 134% year-on-year
The price to earnings (P/E) is 10% higher than the last 4 quarters average of 16.8
AHCO's P/B is 42% lower than its 5-year quarterly average of 1.5 but 9% higher than its last 4 quarters average of 0.8
AHCO's equity is up by 7% year-on-year
The stock's price to sales (P/S) is 52% less than its 5-year quarterly average of 0.9 but 8% more than its last 4 quarters average of 0.4
Efficiency
How efficient is AdaptHealth business performance
The ROA has soared by 140% YoY and by 6% QoQ
The company's return on equity has surged by 136% YoY
The company's return on invested capital rose by 2.4% QoQ
Dividends
What is AHCO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AHCO.
Financial health
How did AdaptHealth financials performed over time
The total assets is 59% more than the total liabilities
AHCO's quick ratio is down by 24% year-on-year and by 7% since the previous quarter
The current ratio has declined by 13% year-on-year
The debt is 18% greater than the equity
AHCO's debt to equity is down by 18% year-on-year and by 4.1% since the previous quarter
The debt is down by 13% year-on-year and by 2.4% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.